489 related articles for article (PubMed ID: 32716553)
21. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
22. Electronic Cigarette Aerosol Is Cytotoxic and Increases ACE2 Expression on Human Airway Epithelial Cells: Implications for SARS-CoV-2 (COVID-19).
McAlinden KD; Lu W; Ferdowsi PV; Myers S; Markos J; Larby J; Chia C; Weber HC; Haug G; Eapen MS; Sohal SS
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33802256
[TBL] [Abstract][Full Text] [Related]
23. Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Cytokine Pathways Involved in COVID-19 After Rhinovirus Infection in Asthma Patients.
Dai W; Cao D; Zhang W; Wei Y; Ding D; Li B; Gao Y; Zhao L; Jiang Y; Kong X
Med Sci Monit; 2020 Dec; 26():e928861. PubMed ID: 33315853
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of severe coronavirus disease 2019 patients with chronic obstructive pulmonary disease.
Liang H; Lu R; Li Y; Pan P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1695-1703. PubMed ID: 36748380
[TBL] [Abstract][Full Text] [Related]
25. Role of Human Antigen R (HuR) in the Regulation of Pulmonary ACE2 Expression.
Aloufi N; Haidar Z; Ding J; Nair P; Benedetti A; Eidelman DH; Gallouzi IE; Di Marco S; Hussain SN; Baglole CJ
Cells; 2021 Dec; 11(1):. PubMed ID: 35011584
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease.
Peng Y; Wang ZN; Chen SY; Xu AR; Fang ZF; Sun J; Zhou ZQ; Hou XT; Cen LJ; Ma JJ; Zhao JC; Guan WJ; Wang DY; Zhong NS
Am J Physiol Lung Cell Mol Physiol; 2022 May; 322(5):L712-L721. PubMed ID: 35318858
[TBL] [Abstract][Full Text] [Related]
27. Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases.
Guan WJ; Liang WH; Shi Y; Gan LX; Wang HB; He JX; Zhong NS
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2645-2655.e14. PubMed ID: 33684635
[TBL] [Abstract][Full Text] [Related]
28. Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective.
Skevaki C; Chinthrajah RS; Fomina D; Rohde G; Cao S; He Z; Serdotetskova S; Seidemann C; Grünewaldt A; Vengadeswaran A; Xie M; Karsonova A; Karaulov A; Nadeau KC; Chung HR; Renz H
J Allergy Clin Immunol; 2023 Jan; 151(1):110-117. PubMed ID: 36336123
[TBL] [Abstract][Full Text] [Related]
29. Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease.
Osan J; Talukdar SN; Feldmann F; DeMontigny BA; Jerome K; Bailey KL; Feldmann H; Mehedi M
Microbiol Spectr; 2022 Aug; 10(4):e0045922. PubMed ID: 35862971
[TBL] [Abstract][Full Text] [Related]
30. Is asthma an exclusionary condition for SARS-CoV-2 infection in China? -the relationship between asthma and COVID-19.
Ma X; Wang L; Liu L; Yang C; Gai Z
J Asthma; 2021 Oct; 58(10):1337-1339. PubMed ID: 32600166
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 and bronchial asthma: current perspectives.
Hojo M; Terada-Hirashima J; Sugiyama H
Glob Health Med; 2021 Apr; 3(2):67-72. PubMed ID: 33937568
[TBL] [Abstract][Full Text] [Related]
32. Asthma and COPD as co-morbidities in patients hospitalised with Covid-19 disease: a global systematic review and meta-analysis.
Finnerty JP; Hussain ABMA; Ponnuswamy A; Kamil HG; Abdelaziz A
BMC Pulm Med; 2023 Nov; 23(1):462. PubMed ID: 37993829
[TBL] [Abstract][Full Text] [Related]
33. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.
Oh TK; Song IA
BMC Pulm Med; 2021 Jan; 21(1):12. PubMed ID: 33407347
[TBL] [Abstract][Full Text] [Related]
34. Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population.
Huang BZ; Chen Z; Sidell MA; Eckel SP; Martinez MP; Lurmann F; Thomas DC; Gilliland FD; Xiang AH
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3621-3628.e2. PubMed ID: 34389242
[TBL] [Abstract][Full Text] [Related]
35. Asthma and COVID-19 pandemic: focus on the eosinophil count and ACE2 expression.
Kanannejad Z; Alyasin S; Esmaeilzadeh H; Nabavizadeh H; Amin R
Eur Ann Allergy Clin Immunol; 2022 Nov; 54(6):284-289. PubMed ID: 34503323
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
Öztürk AB; Çağlayan B
Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
[No Abstract] [Full Text] [Related]
37. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
Nagy B; Fejes Z; Szentkereszty Z; Sütő R; Várkonyi I; Ajzner É; Kappelmayer J; Papp Z; Tóth A; Fagyas M
Int J Infect Dis; 2021 Feb; 103():412-414. PubMed ID: 33249290
[TBL] [Abstract][Full Text] [Related]
38. Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma.
Kermani NZ; Song WJ; Badi Y; Versi A; Guo Y; Sun K; Bhavsar P; Howarth P; Dahlen SE; Sterk PJ; Djukanovic R; Adcock IM; Chung KF;
Respir Res; 2021 Jan; 22(1):10. PubMed ID: 33413387
[TBL] [Abstract][Full Text] [Related]
39. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
Shin EK; Choi HY; Hayes N
Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
[TBL] [Abstract][Full Text] [Related]
40. Severe COVID-19 among patients with asthma and COPD: a report from the Swedish National Airway Register.
Karlsson Sundbaum J; Vanfleteren LEGW; Konradsen JR; Nyberg F; Ekberg-Jansson A; Stridsman C
Ther Adv Respir Dis; 2021; 15():17534666211049738. PubMed ID: 34623194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
